Skip to content

Medtronic plc

MDT · XNYS

CIK 1613103fmd_190S1JB54J7W2HEY8779XJ1VQ2Manufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard

Coverage: Apr 28, 2012 to Jul 31, 2026, 54 periods

Income Statement · Annual · Millions · USD
Line itemFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Total revenues29,71029,95330,55728,91330,11731,68631,22732,36433,53736,364
Cost of revenue9,2949,0679,1559,42410,48310,14510,71911,21611,63212,721
Net interest income–––––186386597511383
Gross profit20,41920,89821,40219,48919,63421,54120,50821,14821,90523,643
Research and development2,1932,2562,3302,3312,4932,7462,6962,7352,7322,873
Selling, general and administrative10,01810,23810,41810,10910,14810,29210,41510,73610,84911,784
Operating income5,3836,6406,2684,7914,4845,7525,4855,1445,9556,467
Interest expense1,0941,1461,4441,092925553636719729715
Other non-operating income (expense)313181373356336318515412402384
Income before taxes4,6025,6755,1974,0553,8955,5175,3644,8375,6286,136
Income tax expense5782,580547(751)2654561,5801,1339361,299
Net income from continuing operations4,0243,0954,6504,8063,6305,0613,7843,7044,6924,837
Net income4,0283,1044,6314,7893,6065,0393,7583,6764,6624,801
Net income to common shareholders––––––––––